Cancer Investigation, Volume 33, Issue 5 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 33, Issue 5 (2015)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Volume 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Vol 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

ORIGINAL ARTICLE

Article
Diffusion Weighted Imaging and Apparent Diffusion Coefficient in 3 Tesla Magnetic Resonance Imaging of Breast Lesions
Rocchina Caivano, Antonio Villonio, Felice D’Antuono, Matilde Gioioso, Paola Rabasco, Giancarlo Iannelli, Alexis Zandolino, Antonella Lotumolo, Giuseppina Dinardo, Luca Macarini, Giuseppe Guglielmi & Aldo Cammarota
Pages: 159-164
Published online: 01 Apr 2015
AbstractforDiffusion Weighted Imaging and Apparent Diffusion Coefficient in 3 Tesla Magnetic Resonance Imaging of Breast Lesions | Full Text | References | PDF (266.2 KB)
  • 133 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer
Jinghui Zhang, Chailan Zhang, Lin Hu, Yin He, Zeya Shi, Siyuan Tang & Yuxiang Chen
Pages: 165-171
Published online: 01 Apr 2015
AbstractforAbnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer | Full Text | References | PDF (540.4 KB)
  • 894 Views
  • 39 CrossRef citations
  • 0Altmetric
Article
A Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma
Mitesh J. Borad, Hani M. Babiker, Stephen Anthony, Monica Mita, Aby Buchbinder, Taha Keilani & Jean Grem
Pages: 172-179
Published online: 06 Apr 2015
AbstractforA Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma | Full Text | References | PDF (343.3 KB)
  • 208 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Stereotactic Body Radiotherapy for Oligometastases Confined to the Para-Aortic Region: Clinical Outcomes and the Significance of Radiotherapy Field and Dose
Young-Seok Seo, Mi-Sook Kim, Chul-Koo Cho, Hyung-Jun Yoo, Won-Il Jang, Kum-Bae Kim, Dong-Han Lee, Sun-Mi Moon & Hoy-Rak Lee
Pages: 180-187
Published online: 01 Apr 2015
AbstractforStereotactic Body Radiotherapy for Oligometastases Confined to the Para-Aortic Region: Clinical Outcomes and the Significance of Radiotherapy Field and Dose | Full Text | References | PDF (346.6 KB)
  • 227 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Cyberknife Treatment for Low and Intermediate Risk Prostate Cancer
B. Detti, P. Bonomo, L. Masi, R. Doro, S. Cipressi, C. Iermano, I. Bonucci, D. Franceschini, V. Di Cataldo, L. Di Brina, M. Baki, G. Simontacchi, I. Meattini, M. Carini, S. Serni, G. Nicita & L. Livi
Pages: 188-192
Published online: 01 Apr 2015
AbstractforCyberknife Treatment for Low and Intermediate Risk Prostate Cancer | Full Text | References | PDF (113 KB)
  • 223 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients
H. Eggemann, J. Ehricke, T. Ignatov, F. Fettke, A. Semczuk, S. D. Costa & A. Ignatov
Pages: 193-196
Published online: 01 Apr 2015
AbstractforPlatelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients | Full Text | References | PDF (333.8 KB)
  • 192 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Down Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung Cancer
Huaying Sheng, Lisha Ying, Lei Zheng, Dan Zhang, Chihong Zhu, Junzhou Wu, Jianguo Feng & Dan Su
Pages: 197-204
Published online: 06 Apr 2015
AbstractforDown Expression of FBP1 Is a Negative Prognostic Factor for Non–Small-Cell Lung Cancer | Full Text | References | PDF (564.7 KB)
  • 578 Views
  • 15 CrossRef citations
  • 0Altmetric

Explore articles